Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Novel insights into genomic classification and prognosis in AML

Lars Bullinger, MD, of Charité University of Medicine, Berlin, Germany, discusses novel insights into genomic classification and prognosis of acute myeloid leukemia (AML) based on a pan-European public-private partnership, The Harmony Alliance. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).